Excuse Rights in Private Equity Explained: When an LP Can Opt Out of a Deal and Why GPs Hate Them

An excuse right is a clause in a private equity fund's limited partnership agreement that lets a specific limited partner (LP) sit out one deal, without penalty, when that deal conflicts with the LP's regulatory obligations or internal policy. The concept sounds simple, but as Global Legal Insights notes, excuse rights now shape everything from subscription-line borrowing bases to how fairly a general partner (GP) treats its investor base.

Start with the plain-English version. A private equity fund is a blind pool: you commit capital up front, and the GP decides which companies to buy without asking your permission deal by deal. An excuse right punches a narrow hole in that arrangement. It lets one LP say, "not this one," for a specific investment, usually because the deal would put that LP in legal or reputational trouble, not because the LP simply changed its mind about the opportunity.

The cleanest example involves banks. Under Section 13 of the Bank Holding Company Act, commonly called the Volcker Rule, a banking entity that sponsors or advises a private equity fund faces strict limits on transactions between the bank and that fund's portfolio companies. The OCC's Volcker Rule FAQ lays out how a "covered transaction" between a bank and a fund it manages can trigger the same restrictions that apply between a bank and its own affiliates. Picture a bank-affiliated LP committed to a buyout fund that then wants to acquire a company where the bank already holds a lending relationship. If closing that deal would create a prohibited transaction under the BHC Act, the bank-affiliated LP invokes its excuse right, sits out that one investment, and stays in the fund for everything else.

Pension funds use the same mechanism for a different reason. A public pension plan with a statutory or board-mandated exclusion on tobacco, firearms, or private prisons will negotiate an excuse right so it never has to fund a drawdown into a company on its restricted list. The PRI's technical guide on ESG provisions describes this as one of four common ways ESG concerns show up in fund documents, sitting alongside broader investment restrictions, decision-making commitments, and reporting rights. The distinction matters: a fund-wide investment restriction stops the GP from buying a certain type of company at all, for every LP. An excuse right is narrower and investor-specific. It lets one LP opt out while the rest of the fund proceeds as planned.

How Excused Capital Actually Works

Here is where the "opt-out" framing gets sloppy. An excuse right doesn't mean the LP pays nothing and walks away clean. It means the LP is carved out of one transaction's economics while remaining fully bound to the fund everywhere else. The mechanics break down like this:

• The capital call. When the GP sends a drawdown notice for the excused deal, the excused LP simply doesn't receive a request for that portion. Its capital account is never charged for that investment.
• Reallocation. The dollar amount the excused LP would have funded gets reallocated pro rata across the remaining LPs, who fund a slightly larger share of that specific deal relative to their overall commitment.
• The waterfall. Because the excused LP never funded the deal, it has no economic interest in it. It receives no distributions when that portfolio company sells, and per Nishith Desai Associates' analysis of excuse provisions, it is typically excused pro rata from that deal's specific expenses and its share of carried interest tied to that investment.
• Fees keep running. The excused LP still pays its full share of fund-level management fees, since those are calculated off total committed capital, not deployed capital. It also still shares in fund-level expenses that aren't deal-specific, like fund administration and audit costs.

Subscription-line financing adds a wrinkle most LPs never think about until it bites them. Funds routinely borrow against undrawn commitments through a subscription line, using the LP base as collateral. When a lender calculates the fund's borrowing base, an excused investor's capital tied to that specific deal has to come out of the calculation. Global Legal Insights notes that lenders generally limit the exclusion to the excused portion, for the period that specific borrowing stays outstanding, rather than yanking the LP's entire commitment out of the collateral pool. Some European and Asian lenders go further and write in a hard cap: if aggregate excused capital across all LPs and all deals exceeds something like 15% to 20% of uncalled capital at any one time, that triggers an event of default on the credit facility. Funds push back hard on that term, since excuse rights say nothing about an LP's creditworthiness or willingness to fund capital calls generally.

There is also a timing question that trips up first-time fund investors. An excuse right usually has to be exercised prospectively, before the capital call closes, not retroactively after the deal is already funded. That means the GP typically flags in the drawdown notice that a given investment may fall within an LP's negotiated exclusion, and the LP has a short window, often five to ten business days, to confirm it wants out. If the LP misses that window, the default position in most LPAs is participation, not exclusion, so a distracted back-office team can accidentally waive a right the fund spent months negotiating. Some sophisticated LPs solve this by requiring the GP to send a standing notice for any deal that touches a restricted sector, rather than relying on the LP to catch it during a busy fundraising or drawdown cycle.

Mechanism	Who it affects	Effect on capital account	Effect on fees
Excuse right	One LP, one deal, for cause (regulatory or policy conflict)	Not charged for that deal; no share of its waterfall	Still pays full management fee and non-deal expenses
Investment restriction	Entire fund, every LP	GP cannot pursue the deal at all	Not applicable, the deal never happens
Excused capital (aggregate)	Fund-wide total across all excuse events	Tracked against sub-line borrowing base caps	No direct fee effect, but can affect leverage capacity
Default (non-payment)	One LP, fund-wide consequence	Charged, then penalized for non-payment	Often loses future distributions or faces forced sale of interest

Why GPs Push Back On Broad Excuse Rights

GPs don't hate excuse rights out of stubbornness. They resist broad ones for three concrete reasons.

First is portfolio construction risk. A buyout fund's model assumes every LP participates in every deal in roughly the same proportion. If a large LP can excuse itself from a chunk of deals, the remaining LPs end up more concentrated in whatever's left, and the fund's actual risk profile drifts from what was pitched during fundraising. A GP running a $2 billion fund with a 20-deal target can absorb one bank-affiliated LP sitting out a handful of conflicted transactions. It gets harder to model if excuse rights multiply across a diverse LP base with different ESG mandates, different sanctioned-country lists, and different regulatory triggers.

Second is fairness among LPs. If one large institutional investor gets a broad excuse right covering entire sectors, while a smaller LP gets none, the smaller LP is effectively subsidizing risk exposure the larger LP avoided. GPs know this creates friction at the next fundraise, when the LPs compare notes.

Third, and this is the sharpest edge, is most-favored-nation (MFN) exposure. Most institutional LPAs include an MFN clause that lets other LPs elect into favorable terms granted to any single investor. EBADAT Law's analysis of GP/LP negotiations points out that MFN clauses let other LPs adopt an excuse right that was originally granted to one investor for a genuine regulatory reason, like the Volcker Rule conflict described above. The risk is that LPs without any real regulatory need start electing the same excuse right opportunistically, cherry-picking their way out of deals they simply think will underperform, rather than deals that create legal exposure. That turns a narrow accommodation into a portfolio-wide adverse-selection problem, where the GP loses committed capital exactly when a deal needs it and keeps it exactly when LPs are happy to fund. ILPA's own commentary, cited in P+P Pöllath's review of ILPA and other influences on LPA terms, flags this tension directly. ILPA acknowledges LPs have legitimate reasons to want excuse rights, while also noting that unchecked proliferation of side letters undermines the uniform treatment the LPA is supposed to provide.

ILPA's push toward a Model Limited Partnership Agreement, built with roughly twenty attorneys representing both GPs and LPs, tries to address this friction structurally. One goal of publishing a standardized, publicly available template is to reduce how much substantive negotiation happens deal-by-deal in bespoke side letters, since every side letter negotiation adds legal cost that eventually gets passed back to the fund as an organizational expense. The tradeoff GPs face is real: adopting a uniform, investor-favorable template like ILPA's reduces negotiation friction and signals fairness to prospective LPs, but it also limits a GP's ability to offer a strategically important anchor investor better or more bespoke terms than smaller LPs receive, terms that anchor investors sometimes demand as a condition of writing the first, largest check in a new fund.

The ESG and Volcker-Driven Surge

Excuse rights used to be a niche ask, mostly from banks navigating the Volcker Rule and a handful of public pensions with statutory restricted lists. That's changed. P+P Pöllath's analysis states that a "significant number" of investors now request excuse rights tied to ESG issues specifically, a category that wasn't even addressed in ILPA's Principles 3.0 when that framework was published, and one ILPA has since flagged as growing in importance.

Two forces are pushing this. Regulatory disclosure regimes, particularly the EU's Sustainable Finance Disclosure Regulation, have forced GPs to formalize how they think about ESG risk in underwriting, which makes it easier for LPs to point to a specific policy and ask for a matching contractual carve-out. At the same time, a wider range of institutional LPs, not just pensions with legacy tobacco or firearms restrictions, now maintain internal exclusion lists tied to climate policy, human rights screens, or reputational risk categories set by their own boards. Once a GP grants one LP an ESG-linked excuse right, MFN elections mean the practical scope of that carve-out can spread across the LP base without the GP renegotiating each side letter individually.

Nishith Desai's review of excuse provisions in India-focused funds shows this isn't a US or European phenomenon either. Indian GPs raising from global LPs, particularly development finance institutions and sovereign-linked investors, now face the same ESG and sanctions-driven excuse right requests that have become standard in North American and European fundraises, layered on top of SEBI's own regulatory framework for domestic funds.

What To Ask Before You Sign

If you're an LP negotiating a fund commitment and you think you'll need an excuse right, ask these questions before you sign the subscription agreement, not after the first drawdown notice arrives. Ask whether your excuse right needs to be tied to an objective, pre-defined trigger, such as a named regulatory statute or a specific written policy you can attach as an exhibit, versus a vague standard that leaves the GP room to dispute whether your trigger actually applies. A specific trigger is easier to invoke without a fight. Ask how the GP will handle the mechanics of notice: will you get advance warning before a capital call goes out on a deal that might trigger your right, or only after the fact? Ask what happens to your pro rata share of fund-level expenses tied to that deal specifically, since "excused from carry" doesn't automatically mean "excused from every cost." Ask whether the fund's subscription-line lender caps aggregate excused capital, and if so, what happens if your exclusion pushes the fund past that cap. Finally, check the MFN language: does it let you elect into excuse rights other LPs negotiated, and does it let other LPs elect into yours. That answer tells you whether your carefully negotiated, regulator-driven carve-out might quietly become a tool other LPs use to dodge deals for reasons that have nothing to do with your original rationale.

Frequently Asked Questions

Is an excuse right the same thing as an opt-out clause?

They describe the same mechanism, but "excuse right" is the term used in LPAs and side letters, while "opt-out" is a looser, plain-English label. Both refer to an LP's contractual ability to sit out one specific investment for cause, without breaching the fund agreement.

Can an LP use an excuse right just because it dislikes a deal?

Generally no. Excuse rights are drafted around specific, pre-agreed triggers, typically a named law like the Volcker Rule or a documented internal ESG or exclusion policy. An LP that simply wants to skip a deal it thinks will underperform doesn't have grounds to invoke the clause, though MFN elections can sometimes blur this line in practice.

Does an excused LP still owe management fees on the excused deal?

Yes. Management fees during the investment period are typically calculated on total committed capital, not on capital actually deployed into specific deals, so an excused LP keeps paying its full management fee even though it has no economic stake in the excused investment.

Do excuse rights show up in every private equity fund?

No. They're most common in funds with bank-affiliated LPs, public pension investors, sovereign wealth funds, or development finance institutions, all of which carry external regulatory or policy mandates. A fund raising primarily from family offices or funds of funds without those constraints may include few or no excuse rights at all.

Author Disclosure: Jeff Barnes, MBA has no personal position in any company, fund, or platform named in this article. Angel Investors Network has no current commercial relationship with any party mentioned. AIN provides marketing and education services, not investment advice. Past performance does not guarantee future results. All investments involve risk, including loss of principal.